EFEMP2 upregulates PD-L1 expression via EGFR/ERK1/2/c-Jun signaling to promote the invasion of ovarian cancer cells

被引：0
|
作者：
Xin Shen
Xuli Jin
Shuang Fang
Jie Chen
机构：
[1] Shandong University,Department of Maternal and Child Health, School of Public Health, Cheeloo College of Medicine
[2] Shandong University,Department of Epidemiology, School of Public Health, Cheeloo College of Medicine
[3] Jinan Medical Center Management Committee,undefined
来源：
Cellular & Molecular Biology Letters | / 28卷
关键词：
Ovarian cancer; EFEMP2; PD-L1; EGFR; ERK1/2/c-Jun pathway; Trametinib; Afatinib;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] BTN3A3 inhibits the proliferation, migration and invasion of ovarian cancer cells by regulating ERK1/2 phosphorylation
    Chen, Sihan
    Li, Zhangyun
    Wang, Yanyan
    Fan, Shaohua
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [32] Cancer-associated fibroblasts promote PD-L1 expression in mice cancer cells via secreting CXCL5
    Li, Ziqian
    Zhou, Jiawang
    Zhang, Junjie
    Li, Shiying
    Wang, Hongsheng
    Du, Jun
    INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (07) : 1946 - 1957
  • [33] FAM83A drives PD-L1 expression via ERK signaling and FAM83A/PD-L1 co-expression correlates with poor prognosis in lung adenocarcinoma
    Fengrui Zhou
    Xin Wang
    Fang Liu
    Qingwei Meng
    Yan Yu
    International Journal of Clinical Oncology, 2020, 25 : 1612 - 1623
  • [34] Autocrine activation of canonical BMP signaling regulates PD-L1 and PD-L2 expression in human dendritic cells
    Martinez, Victor G.
    Hidalgo, Laura
    Valencia, Jaris
    Hernandez-Lopez, Carmen
    Entrena, Ana
    del Amo, Beatriz G.
    Zapata, Agustin G.
    Vicente, Angeles
    Sacedon, Rosa
    Varas, Alberto
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2014, 44 (04) : 1031 - 1038
  • [35] Melatonin inhibits EMT and PD-L1 expression through the ERK1/2/FOSL1 pathway and regulates anti-tumor immunity in HNSCC
    Luo, Xinyue
    Chen, Yang
    Tang, Hokeung
    Wang, Hui
    Jiang, Erhui
    Shao, Zhe
    Liu, Ke
    Zhou, Xiaocheng
    Shang, Zhengjun
    CANCER SCIENCE, 2022, 113 (07) : 2232 - 2245
  • [36] Z-guggulsterone induces PD-L1 upregulation partly mediated by FXR, Akt and Erk1/2 signaling pathways in non-small cell lung cancer
    Tian, Han
    Gui, Yanni
    Wei, Yuanhui
    Shang, Bin
    Sun, Jian
    Ma, Shan
    You, Wenjie
    Jiang, Shujuan
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 93
  • [37] CALD1 promotes the expression of PD-L1 in bladder cancer via the JAK/STAT signaling pathway
    Li, Cheng
    Yang, Fuhan
    Wang, Ruiliang
    Li, Wei
    Maskey, Niraj
    Zhang, Wentao
    Guo, Yadong
    Liu, Shenghua
    Wang, Hong
    Yao, Xudong
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (18)
  • [38] Fusobacterium nucleatum upregulates the immune inhibitory receptor PD-L1 in colorectal cancer cells via the activation of ALPK1
    Duizer, Coco
    Salomons, Moniek
    van Gogh, Merel
    Graeve, Sanne
    Schaafsma, Freke A.
    Stok, Maaike J.
    Sijbranda, Merel
    Sivasamy, Raghuvandhanan Kumarasamy
    Willems, Rob J. L.
    de Zoete, Marcel R.
    GUT MICROBES, 2025, 17 (01)
  • [39] AKT/mTOR Signal Cascade and Expression of PD-1, PD-L1, and PD-L2 in Gastric Cancer
    L. V. Spirina
    A. V. Avgustinovich
    S. G. Afanas’ev
    I. V. Kondakova
    M. Yu. Volkov
    A. Yu. Dobrodeev
    A. I. Boronkina
    Bulletin of Experimental Biology and Medicine, 2020, 170 : 75 - 78
  • [40] NNK activates ERK1/2 and CREBATF-1 via β-1-AR and EGFR signaling in human lung adenocarcinoma and small airway epithelial cells
    Laag, E.
    Majidi, M.
    Cekanova, M.
    Masi, T.
    Takahashi, T.
    Schuller, H. M.
    INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (07) : 1547 - 1552
12345